Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-26

FDA Approved: LISINOPRIL — Supplemental Application (Solco healthcare U.S., LLC)

View source ↗

Summary

The FDA approved a supplemental application for lisinopril filed by Solco Healthcare U.S., LLC under an ANDA. The action authorizes changes to an already approv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lisinopril (Lisinopril)

Snippet

SUPPL AP for LISINOPRIL (LISINOPRIL)